Navigation Links
EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
Date:9/22/2008

AMSTERDAM, September 22 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) following an allogeneic bone marrow transplantation.

"Following the orphan drug designation granted by the FDA for our lead product ATIR(TM), this is another important milestone in the development of ATIR(TM) as a novel approach which may enable a safe and potentially life-saving mismatched bone marrow transplantation as a treatment option for end-stage blood cancer patients" says Dr. Manja Bouman, Chief Executive Officer of Kiadis Pharma.

The EMEA's orphan drug designation is reserved for new therapies being developed to treat life-threatening or chronically debilitating diseases or conditions that are relatively rare in the European Union and for which no satisfactory therapy is available. The orphan drug designation provides for incentives to support research and development, exemption from user fees and a ten-year period of market exclusivity in the European Union after product approval.

For the complete press release please go to: http://www.kiadis.com/news

About Kiadis Pharma

Kiadis Pharma is an oncology focused pharmaceutical development company with three products in different phases of clinical development. The company develops products that offer novel treatment options for terminally ill cancer patients and address significant unmet medical needs. The key focus indication for Kiadis Pharma is limitations and complications of bone marrow transplantation procedures performed in blood cancer patients. Kiadis Pharma is headquartered in Amsterdam, The Netherlands with facilities in Groningen, The Netherlands and Montreal, Canada. For more information about Kiadis Pharma, please visit '/>"/>

SOURCE Kiadis Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. NIH grants $750,000 to develop device to determine temperature of neonates brain
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
7. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
8. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...LVILLE, N.Y., Dec. 3 Nikon Corpora..., announced today that it has signed a licensing a...e rights to use the Stochastic Optical Reconstruct... of the agreement, Nikon will manufacture STORM en...N-STORM name. ,, Nikon Corporation President, ...
(Date:12/3/2009)...LTHAM, Mass., Dec. 3 Inv... global leader in enabling individuals to take cha...rapid diagnostics and health management, has decla...Convertible Perpetual Preferred Stock ( IMA-PB). T...ck in an amount per share equal to the quotient of...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.c...available in its catalogue: ,, Neurostimulatio....reportlinker.com/p0164232/Neurostimulation---A-Gl...rostimulation market stands enthused by the growin... in age-related diseases such as, Parkinson,s, and...
(Date:12/2/2009)...TUSTIN, Calif., Dec. 2 P...day reported completion of patient enrollment in a...174; in patients with relapsed glioblastoma multif...otara is a targeted monoclonal antibody linked to ...treatment for GBM. Cotara specifically targets ce...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...J., Feb. 5 Sopherion Therapeutics, LLC, a biophar...commercialization of anti-cancer therapies, today ...I study of nonpegylated liposomal doxorubicin (Myo... Research . The study was supported by a grant fr...ancer Cooperative Group (SOLTI). , , The study re...
...ins one of the most serious diseases worldwide, cl...er year in tropical and sub-tropical regions, the ...age. Efforts to eliminate this mosquito-borne ill...e are growing concerns about resistance to insecti...me Research ( www.genome.org ), researchers have ...
..., Feb. 4 Illinois, a state that hosted,the first ...ecades ago, made,history again this week with the ...of higher yielding soybean technology. The techno... trait, is expected to be the platform for,Monsant... , (Photo: http://www.newscom.com/cgi-bin/pr...
Other Biology Technology:Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 2Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 3Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 4Mosquito genes linked to insecticide resistance may be new target in fight against malaria 2Historic Seed Delivery Made in Illinois for First New Soybean Varieties With the Greater Yield Potential of Roundup Ready 2 Yield(TM) 2Historic Seed Delivery Made in Illinois for First New Soybean Varieties With the Greater Yield Potential of Roundup Ready 2 Yield(TM) 3
(Date:12/2/2009)...ELPHIA Mexican-American adolescents exposed to ci...o pick up the habit themselves, and this may be pa...oking initiation, according to new study findings....n the United States and highlights the global impl...ork Convention on Tobacco Control, which includes ...
(Date:12/2/2009)...AYETTE, Ind. ╤ A Smoky Mountain forest,s woo...lay a role in how forest understories recover from... , Despite heavy logging in portions of the fore...um plants on the secondary forest floor was simila... Purdue assistant professor of forestry and natura...
(Date:12/2/2009)...- A team comprised of undergraduate students from ...nors in a national poster contest hosted by the In... (ISPE). , The annual contest highlights the res...month at the ISPE Annual Meeting in San Diego, Cal...a Posterior Criciate Ligament Tensioning Device," ...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2World Day to Combat Desertification focuses on human security 8869 1World Day to Combat Desertification focuses on human security 8869 2Innovative system for monitoring coastline processes 8867 1Innovative system for monitoring coastline processes 8867 2The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 1The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 2
...er bears (tardigrades) are the first animals in th...d radiation of space. This has been established b...versity in Sweden. , It has been nearly a year si...croscopic water bears sent up on a twelve-day spac...s supported by the European Space Agency, was to f...
...is release is available in German . , Drought...dreae, Director at the Max Planck Institute for Ch... affect the when, where and how much of rainfall. ...n as varied as they have been inconsistent. Andrea...e through the sometimes contradictory effects that...
...EMAN, Mont. -- Armed guards once kept polar bears ...ngi on the island of Svalbard between Norway and t...usk-oxen while gathering fungi in Greenland. , It...xperts on fungi asked if they would face grizzly b...ersity mycologist who hosted a recent Internationa...
Other Biology News:Moderate quantities of dirt make more rain 2Moderate quantities of dirt make more rain 3Moderate quantities of dirt make more rain 4Moderate quantities of dirt make more rain 5International experts collect alpine fungi in Beartooth Mountains of Montana 2
...rrers operate without any moving parts such as mot...G Magnetic Stirrers 100% wear-free and maintenance...an be hermetically sealed, making it inaccessible ...OMAG Magnetic Stirrers are particularly suitable f...
...nation, which prevents false positive results ,Des...plifications without degrading native nucleic acid...d for use with GeneAmp PCR core reagents and GeneA...r Prevention Kit provides reagents for a simple ye...
...safe KS convince with an optimum product, personne... frameless slanted window does not obscure the vie...kes it easy to work in a relaxed posture. The larg...ensures ease of handling. ,The eye-level display ...
Fluoroskan Ascent FL, 100-240 V from Thermo Scientific
Biology Products: